

Diurnal Submits Market Authorisation Application For Chronocort


Diurnal Submits New Drug Application For Aklindi Sprinkle In US


(Sharecast News) - Specialty pharmaceutical company Diurnal Group has submitted a 'New Drug Application' (NDA) to the US Food and Drug Administration ...


Diurnal Primary Focus Remains On Progressing Flagship Products


Diurnal To Explore Further Tests As Testosterone Treatment Does Well


Diurnal Loss Narrows On Research Expenses And Alkindi Launch


(Alliance News) - Pharmaceutical firm Diurnal Group PLC's shareholders on Friday approved its GBP5.9 million fundraise completed earlier in the day.Di...


(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced a conditional placing of new ordinary shares in the company and the launch...